Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry

Showing results (301-310 of 312) with videos related to

Pageof 32
Sort By:
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Fertility and Sterility|May 21, 2021
Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutationCristina E Trevino, J Christopher Rounds, Krista Charen, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Association between halo nevi and melanoma in adults: A multicenter retrospective case seriesDylan Haynes, Jennifer L Strunck, Jordan Said, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
Pediatric Neurology|July 3, 2026
Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research DatabaseSarah Nelson Potter, Carlos Petzold, Katie Garbarini, et al.
Journal of Inherited Metabolic Disease|April 26, 2026
2025 Consensus Clinical Management Guidelines for Niemann-Pick Disease Type CTarekegn Hiwot, Forbes D Porter, Tatiana Bremova-Ertl, et al.
American Journal on Intellectual and Developmental Disabilities|November 19, 2020
Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental DisordersCristan A Farmer, Aaron J Kaat, Audrey Thurm, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial EndpointsLatha Valluripalli Soorya, Camille W Brune, Cristan A Farmer, et al.
American Journal of Human Genetics|November 4, 2017
Mutations in GPAA1, Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and OsteopeniaThi Tuyet Mai Nguyen, Yoshiko Murakami, Eamonn Sheridan, et al.
American Journal of Human Genetics|February 1, 2011
Mutations in prickle orthologs cause seizures in flies, mice, and humansHirotaka Tao, J Robert Manak, Levi Sowers, et al.
Pageof 32

Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Fertility and Sterility|May 21, 2021
Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutationCristina E Trevino, J Christopher Rounds, Krista Charen, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Association between halo nevi and melanoma in adults: A multicenter retrospective case seriesDylan Haynes, Jennifer L Strunck, Jordan Said, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
Pediatric Neurology|July 3, 2026
Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research DatabaseSarah Nelson Potter, Carlos Petzold, Katie Garbarini, et al.
Journal of Inherited Metabolic Disease|April 26, 2026
2025 Consensus Clinical Management Guidelines for Niemann-Pick Disease Type CTarekegn Hiwot, Forbes D Porter, Tatiana Bremova-Ertl, et al.
American Journal on Intellectual and Developmental Disabilities|November 19, 2020
Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental DisordersCristan A Farmer, Aaron J Kaat, Audrey Thurm, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial EndpointsLatha Valluripalli Soorya, Camille W Brune, Cristan A Farmer, et al.
American Journal of Human Genetics|November 4, 2017
Mutations in GPAA1, Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and OsteopeniaThi Tuyet Mai Nguyen, Yoshiko Murakami, Eamonn Sheridan, et al.
American Journal of Human Genetics|February 1, 2011
Mutations in prickle orthologs cause seizures in flies, mice, and humansHirotaka Tao, J Robert Manak, Levi Sowers, et al.
Pageof 32